Table 3.
Region | Sex | Anti-HBs | HBsAg | Anti-HBc | Only anti-HBs | ||||
---|---|---|---|---|---|---|---|---|---|
No. positive/total | Percent | No. positive/total | Percent | No. positive/total | Percent | No. positive/total | Percent | ||
Xianju | Male | 1583/2585 | 61.2 | 352/2585 | 13.6 | 1205/2585 | 46.6 | 1010/2585 | 39.1 |
Female | 2019/3301 | 61.2 | 383/3301 | 11.6 | 1475/3301 | 44.7 | 1227/3301 | 37.2 | |
Total | 3602/5886 | 61.2 | 735/5886 | 12.6 | 2680/5886 | 45.7 | 2237/5886 | 38.1 | |
Anji | Male | 673/1595 | 42.2 | 154/1595 | 9.7 | 572/1595 | 35.9 | 422/1595 | 26.5 |
Female | 1002/2416 | 41.5 | 180/2416 | 7.5 | 867/2416 | 35.9 | 573/2416 | 23.7 | |
Total | 1675/4011 | 41.8 | 334/4011 | 8.6 | 1439/4011 | 35.9 | 995/4011 | 25.1 |
Percentages of HBV markers were standardized by gender